Tecartus
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Tecartus, covering 2020-09-10 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab [Phase 1, Phase 2]